Gary Friedman
Academic Appointments
- Consulting Professor, Health Research & Policy - Epidemiology
- Member, Stanford Cancer Institute
Key Documents
Contact Information
- Academic Offices
Personal Information Email Tel (510) 891-3542
Professional Overview
Honors and Awards
- Please see CV, - (-)
Graduate & Fellowship Program Affiliations
Community and International Work
Scientific Focus
Current Research Interests
Chronic disease epidemiology, particularly cancer, cardiovascular disease, adverse effects of smoking, alcohol and pharmaceuticals, evaluation of screening tests.
Most of my career has been in the Kaiser Permanente Division of Research where I was Director for 7 years and am still active. I especially enjoy mentoring students and trainees at Stanford.
Publications
- Antihypertensive drugs and lip cancer in non-Hispanic whites. Arch Intern Med. 2012; (16): 1246-51
- Risk of cancer in patients exposed to gabapentin in two electronic medical record systems. Pharmacoepidemiol Drug Saf. 2012; (2): 214-25
- Association of tea consumption and cutaneous squamous cell carcinoma. Nutr Cancer. 2011; (2): 314-8
- Norepinephrine antagonists and cancer risk. Int J Cancer. 2011; (3): 737-8; author reply 739
- Re: a case-control study of levothyroxine and the risk of colorectal cancer. J Natl Cancer Inst. 2011; (21): 1637-9
- Supplement use and risk of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2011; (6): 1145-51

